You are viewing the site in preview mode

Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China

Fig. 2

Kaplan–Meier analysis of survival outcomes. (A) Disease-free survival of all patients. (B) Locoregional recurrence-free survival of all patients. (C) Distant metastasis-free survival of all patients. (D) Overall survival of all patients. (E) Disease-free survival in camrelizumab maintenance subgroup vs. observation subgroup. (F) Locoregional recurrence-free survival in camrelizumab maintenance subgroup vs. observation subgroup. (G) Distant metastasis-free survival in camrelizumab maintenance subgroup vs. observation subgroup. (H) Overall survival in camrelizumab maintenance subgroup vs. observation subgroup

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us